A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy Matti Aapro , H. S. Rugo , Antônio Rossi +10 more 2014 Annals of Oncology 241 citations
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort Paolo A. Ascierto , Ester Simeone , Vanna Chiarion‐Sileni +17 more 2014 Journal of Translational Medicine 161 citations